Literature DB >> 16846639

Structural and inhibitory properties of a plant proteinase inhibitor containing the RGD motif.

Adriana M Nakahata1, Norlene R Bueno, Hugo A O Rocha, Célia R C Franco, Roger Chammas, Clovis R Nakaie, Miriam G Jasiulionis, Helena B Nader, Lucimeire A Santana, Misako U Sampaio, Maria Luiza V Oliva.   

Abstract

Purified from Bauhinia rufa seeds, BrTI is a Kunitz proteinase inhibitor that contains the RGD sequence. BrTI inhibits trypsin (K(iapp) 2.9 nM) and human plasma kallikrein (K(iapp) 14.0 nM) but not other related enzymes. The synthetic peptide YLEPVARGDGGLA-NH(2) (70 microM) inhibited the adhesion to fibronectin of B16F10 (high-metastatic B16 murine mouse melanoma cell line) and of Tm5 (murine melanoma cell lines derived from a non-tumorigenic lineage of pigmented murine melanocytes, melan-a). YLEPVARGEGGLA-NH(2) in which Asp(9) was changed into Glu does not affect the cell attachment. Moreover, this peptide was functional only when the sequence present in the native protein was preserved, since YLIPVARGDGGLA-NH(2) in which Glu(3) was changed into Ile does not interfere with B16F10 and was less effective on Tm5 cell line adhesion. Neither YLEPVARGDGGLA-NH(2), YLIPVARGDGGLA-NH(2) or YLEPVARGEGGLA-NH(2) inhibit the interaction of RAEC (endothelial cell line from rabbit aorta) with fibronectin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846639     DOI: 10.1016/j.ijbiomac.2006.05.008

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  5 in total

1.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

Review 2.  Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets.

Authors:  Camila Ramalho Bonturi; Ana Beatriz Silva Teixeira; Vitória Morais Rocha; Penélope Ferreira Valente; Juliana Rodrigues Oliveira; Clovis Macêdo Bezerra Filho; Isabel Fátima Correia Batista; Maria Luiza Vilela Oliva
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

3.  The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitor.

Authors:  Joana Gasperazzo Ferreira; Paula Malloy Motta Diniz; Cláudia Alessandra Andrade de Paula; Yara Aparecida Lobo; Edgar Julian Paredes-Gamero; Thaysa Paschoalin; Amanda Nogueira-Pedro; Paloma Korehisa Maza; Marcos Sergio Toledo; Erika Suzuki; Maria Luiza Vilela Oliva
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

4.  Novel in vitro inhibitory functions of potato tuber proteinaceous inhibitors.

Authors:  Matthias Fischer; Markus Kuckenberg; Robin Kastilan; Jost Muth; Christiane Gebhardt
Journal:  Mol Genet Genomics       Date:  2014-09-27       Impact factor: 3.291

Review 5.  Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy.

Authors:  Sandhya Srikanth; Zhong Chen
Journal:  Front Pharmacol       Date:  2016-12-08       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.